Abstract: Nuclear imaging is an ideal and useful noninvasive detection technology, is the unique imageology method reflecting the changes of tissue and organ blood flow, metabolism and function qualitatively and quantitatively. Atherosclerotic plaque nuclear imaging using the radioisotope labeled intermediate materials participating in atherosclerosis can discover the early stage lesion. This article focuses on studying the recent developments of the atherosclerosis imaging agents and assessing their clinical prospects.